Subscribe Free
in Maintenance

Dnata awarded UK MHRA certification for Good Distribution Practice

Posted 19 April 2018 · Add Comment

Global air services provider and UK’s leading ground handler, Dnata, has been awarded certification for Good Distribution Practice (GDP) by the UK Medicines and Healthcare Products Regulatory Agency (UK MHRA).

 

The UK MHRA granted Dnata full Wholesaler Dealer Authorisation (WDA) after Dnata completed the organisation’s Good Distribution Programme, while simultaneously investing into cutting-edge pharma handling technology at several of its facilities.

Dnata’s investment includes a sophisticated 24-hour warehouse monitoring system that has the ability to conduct temperature mapping and advise Dnata operators ahead of any deviation in temperature. This, in, turn enables pre-planning, quick response to adapt to adverse weather conditions and assessment of potential transport routes for pharma products.

Temperature mapping is also routinely conducted within Dnata’s facilities in the summer and winter to gauge average temperatures.

This leading-edge technology recently paid dividends when the cold front struck in early March and temperatures across the UK plummeted. Dnata was able to prepare for the severe temperature onslaught, and ensure that all pharmaceuticals handled followed the optimum route, at temperatures that limited the risk of spoilage.

In addition, the company has installed automated handling systems that can store pharmaceuticals at variable temperature ranges.

In order to achieve certification, Dnata was required to either review or make enhancements to its quality systems, operations documentation and facilities management practices – a 12 to 24-month process that it completed in just six months.

“We have invested in pharma-handling facilities across the UK in response to customer demand and in recognition of the growing importance of pharma cold-chain logistics,” said Dnata UK CEO Gary Morgan. 

“With world-class technology already in place at our facilities, the next logical step was to ensure standards compliance and achieve UK MHRA certification.  These initiatives not only demonstrate our ongoing focus on safety and quality, but also reinforce our commitment to our airline customers who operate in the fast-growing pharmaceutical transportation sector. ”

 

* required field

Post a comment

Other Stories
Advertisement
Latest News

Embraer to make impact with debuts at EBACE

Embraer will debut the Phenom 100EV business jet at the European Business Aviation Conference and Exhibition (EBACE) in Geneva, Switzerland, from May 29 to May 31.

Qatar Airways touches down at London Gatwick Airport

Qatar Airways has commenced flights to London Gatwick Airport.

Dubai Airports rolls out first cloud based Flight Information Display Solution

Dubai Airports, in partnership with Samsung Electronics and AirportLabs has rolled out an advanced cloud-based Flight Information Display solution along with System on Chip (SoC) display technology at Dubai International (DXB) and

The delayed Muscat International Airport has now arrived

Oman Airports Management Company (OAMC) successfully opened the new passenger terminal building at New Muscat International Airport last month, as it overcame a plethora of delays over the last two years.

Etihad turns to Boeing to enhance crew satisfaction and improve efficiency

Etihad Airways has contracted Boeing Global Services to provide multiple crew management solutions to support the planning and operation of the airline's 7,500 crewmembers.

Etihad Aviation Group to donate 150,000 meals to charity every year

Etihad Aviation Group has launched a community programme that will deliver 400 meals per day to charity. The initiative will be held throughout 2018 and beyond, with approximately 150,000 meals to be donated every year.

TAA SK0902311218
See us at
GATM BT1004061118MEBAA BT1004121218Cargo BT1004091018Istanbul Airshow BT22018ASDubai BT1004091018EBACE 2018BIAS BT271017161118